ADMA Biologics Newsroom

Key Takeaways From ADMA Biologics Analyst Ratings

BenzingaOct 14 20:02

H.C. Wainwright Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $18

Futu NewsOct 14 18:31

Maintaining Buy Rating on ADMA Biologics Amid Auditor Resignation: Confidence in Fiscal Health and Compliance

TipRanksOct 14 18:17

ADMA Biologics (ADMA) Receives a Buy From Mizuho Securities

TipRanksOct 14 15:00

ADMA Biologics Analyst Ratings

BenzingaSep 20 23:12

Cantor Fitzgerald Reiterates Overweight on ADMA Biologics, Maintains $20 Price Target

BenzingaSep 20 23:12

HC Wainwright & Co. Maintains Buy on ADMA Biologics, Raises Price Target to $18

BenzingaAug 12 18:54

Buy Rating Affirmed for ADMA Biologics Amid Strong Financial Performance and Promising R&D Prospects

TipRanksAug 12 18:30

ADMA Biologics Analyst Ratings

BenzingaAug 9 23:27

Analysts Offer Insights on Healthcare Companies: Paragon 28 (FNA), ADMA Biologics (ADMA) and Veracyte (VCYT)

TipRanksAug 9 20:48

Cantor Fitzgerald Adjusts Price Target on ADMA Biologics to $15 From $10, Maintains Overweight Rating

MT NewswiresJul 9 21:37

ADMA Biologics Analyst Ratings

BenzingaJul 9 21:24

Cantor Fitzgerald Maintains Overweight on ADMA Biologics, Raises Price Target to $15

BenzingaJul 9 21:24

ADMA Biologics Analyst Ratings

BenzingaJun 20 20:15

Cantor Fitzgerald Adjusts ADMA Biologics' Price Target to $10 From $8, Maintains Overweight Rating

MT NewswiresMay 10 23:38

Mizuho Bank: Maintains the ADMA Biologics (ADMA.US) rating, adjusted from buy to buy rating, and adjusted the target price from $10.00 to $12.00.

Zhitong FinanceMay 10 20:04

ADMA Biologics Analyst Ratings

BenzingaMay 10 20:00

Mizuho Maintains Buy on ADMA Biologics, Raises Price Target to $12

BenzingaMay 10 20:00

Strong Financial Performance and Growth Prospects Affirm Buy Rating for ADMA Biologics

TipRanksMay 10 18:55

HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Raises Price Target to $7.5

BenzingaMar 26 18:25